52 An open-label extension (EXT) study of lumacaftor/ivacaftor (LUM/IVA) therapy in patients (pts) aged 6–11 years (yrs) with cystic fibrosis (CF) homozygous for F508del-CFTR

Autor: Chilvers, M., Tian, S., Marigowda, G., Bsharat, M., Hug, C., Solomon, M., Black, P., Rosenfeld, M., Sawicki, G.S., Hoppe, J.
Zdroj: In Journal of Cystic Fibrosis June 2017 16 Supplement 1:S77-S77
Databáze: ScienceDirect